BR0008006A - Métodos e composições para uso em aplicações deperfusão - Google Patents

Métodos e composições para uso em aplicações deperfusão

Info

Publication number
BR0008006A
BR0008006A BR0008006-3A BR0008006A BR0008006A BR 0008006 A BR0008006 A BR 0008006A BR 0008006 A BR0008006 A BR 0008006A BR 0008006 A BR0008006 A BR 0008006A
Authority
BR
Brazil
Prior art keywords
compositions
methods
fluid
applications
composition
Prior art date
Application number
BR0008006-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul E Segall
Harold D Watz
Hal Sternberg
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of BR0008006A publication Critical patent/BR0008006A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
BR0008006-3A 1999-02-03 2000-01-24 Métodos e composições para uso em aplicações deperfusão BR0008006A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/243,921 US6589223B1 (en) 1999-02-03 1999-02-03 Method and compositions for use in perfusion applications
PCT/US2000/001703 WO2000045873A1 (en) 1999-02-03 2000-01-24 Methods and compositions for use in perfusion applications

Publications (1)

Publication Number Publication Date
BR0008006A true BR0008006A (pt) 2001-12-04

Family

ID=22920663

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008006-3A BR0008006A (pt) 1999-02-03 2000-01-24 Métodos e composições para uso em aplicações deperfusão

Country Status (14)

Country Link
US (3) US6589223B1 (cg-RX-API-DMAC7.html)
EP (1) EP1150728A4 (cg-RX-API-DMAC7.html)
JP (2) JP2002536078A (cg-RX-API-DMAC7.html)
CN (1) CN1200742C (cg-RX-API-DMAC7.html)
AR (1) AR022482A1 (cg-RX-API-DMAC7.html)
AU (1) AU765144B2 (cg-RX-API-DMAC7.html)
BR (1) BR0008006A (cg-RX-API-DMAC7.html)
CA (1) CA2362051C (cg-RX-API-DMAC7.html)
EA (1) EA003171B1 (cg-RX-API-DMAC7.html)
IL (1) IL144710A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01007875A (cg-RX-API-DMAC7.html)
TW (1) TW542728B (cg-RX-API-DMAC7.html)
WO (1) WO2000045873A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200107243B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
US7354342B2 (en) * 2003-07-30 2008-04-08 Igt Gaming device having a multiple coordinate award distributor including award percentages
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US8585380B2 (en) 2004-10-07 2013-11-19 Transmedics, Inc. Systems and methods for ex-vivo organ care
US20100121273A1 (en) * 2005-06-22 2010-05-13 Kochanek Patrick M Emergency preservation and resuscitation methods
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US7712094B2 (en) * 2005-12-22 2010-05-04 Alan Joshua Shapiro Method and apparatus for replicating a panoplex onto a storage medium from a master
DK1942726T3 (en) * 2006-04-19 2017-04-10 Transmedics Inc METHODS FOR EX VIVO ORGANIC CARE
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
KR101183965B1 (ko) * 2007-10-05 2012-09-18 후소 야쿠힝 고교 가부시끼가이샤 안정한 탄산수소 이온 함유 약액
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US9247728B2 (en) 2008-01-31 2016-02-02 Transmedics, Inc. Systems and methods for ex vivo lung care
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DK4032401T3 (da) 2011-04-14 2025-12-15 Transmedics Inc Fremgangsmåde til fremstilling af en organplejeopløsning til maskinperfusion ex-vivo af donorlunger
US8579880B2 (en) * 2012-03-01 2013-11-12 Outcome Solutions, Llc Devices and methods for making and administering an intravenous liquid with supersaturated dissolved gas
IL303658B2 (en) 2014-06-02 2024-07-01 Transmedics Inc Ex vivo organ care system
DK3229588T3 (da) 2014-12-12 2025-06-23 Transmedics Inc Anordning og fremgangsmåde til organperfusion
DK3347084T3 (da) 2015-09-09 2021-02-15 Transmedics Inc Aortakanyle til ex vivo-organplejesystem
DK3462861T5 (da) 2016-05-30 2024-01-08 Transmedics Inc Fremgangsmåde til ex vivo-lungeventilati on med et varierende udvendigt tryk

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3677024A (en) 1970-01-20 1972-07-18 Paul E Segall Preservation and storage of biologic materials
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US4001401A (en) 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
EP0185759B2 (en) 1984-06-22 2004-06-02 Btg International Limited Electrolyte solutions and (in vivo) use thereof
US5084377A (en) 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4908350A (en) 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US5210083A (en) 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
WO1989005659A1 (en) 1987-12-24 1989-06-29 Borody Thomas J Orthostatic lavage solutions
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US5082831A (en) 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
CA2066374C (en) 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
EP0663821A4 (en) 1991-08-08 1997-09-17 Leigh D Segel BLOOD SUBSTITUTE WITH FLUOROCARBON.
US5334142A (en) * 1991-09-09 1994-08-02 New York University Selective aortic perfusion system
US5374428A (en) * 1993-03-23 1994-12-20 Kansas State University Research Foundation Supplementation of protein diets with di- and tripeptides
US5407428A (en) 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes
CN1102851C (zh) * 1993-06-04 2003-03-12 生物时间公司 类血浆溶液
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US5730720A (en) 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications

Also Published As

Publication number Publication date
CN1200742C (zh) 2005-05-11
CA2362051A1 (en) 2000-08-10
AU3349700A (en) 2000-08-25
EP1150728A4 (en) 2004-09-29
EA200100855A1 (ru) 2002-02-28
JP2002536078A (ja) 2002-10-29
MXPA01007875A (es) 2002-08-20
JP5180912B2 (ja) 2013-04-10
TW542728B (en) 2003-07-21
US7503913B2 (en) 2009-03-17
JP2009242404A (ja) 2009-10-22
AU765144B2 (en) 2003-09-11
AR022482A1 (es) 2002-09-04
IL144710A0 (en) 2002-06-30
CN1346286A (zh) 2002-04-24
EA003171B1 (ru) 2003-02-27
US20040018966A1 (en) 2004-01-29
US6589223B1 (en) 2003-07-08
ZA200107243B (en) 2002-09-02
US20060088606A1 (en) 2006-04-27
WO2000045873A1 (en) 2000-08-10
EP1150728A1 (en) 2001-11-07
US6991624B2 (en) 2006-01-31
CA2362051C (en) 2010-06-29

Similar Documents

Publication Publication Date Title
BR0008006A (pt) Métodos e composições para uso em aplicações deperfusão
BR9810088A (pt) Suspensões de plaqueta e processos para ressuspender plaquetas
DE60036811D1 (de) Zugangsöffnung mit klip und verwendungsverfahren
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9810745A (pt) Derivados de benzimidazol
CO5690564A2 (es) Medicamento para tratar tejido de miocardio infartado que comprende mioblastos oseos de mamiferos geneticamente modoficados para expresar la proteina sdf-1 de mamifero
BR9906372A (pt) Composição farmaceutica aquosa para aplicação na mucosa
Sejourne et al. Effect of haemodilution on transfusion requirements in liver resection
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
BR0117141A (pt) Cateter e método de uso
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
TW200501932A (en) Sterile combined preparation and manufacture method thereof
KR960013383A (ko) 항혈전성 및 피브린용해성 치료제와 조합하여 사용되는 치료제로서의 폰 빌레브란트 인자(vWF)-함유 농축물의 용도
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
Østergaard et al. Intra-articular corticosteroids in arthritic disease: a guide to treatment
Wang et al. Effectiveness and safeties of hemocoagulase and tranexamic acid to reduce perioperative blood loss in intertrochanteric fracture PFNA fixation
Galois et al. Autologous bone marrow graft and treatment of delayed and non-unions of long bones: technical aspects
SATTERLEE et al. The use of herudin in the transfusion of blood
ES2774102T3 (es) Procedimiento de prevención de fallos de trasplante en un huésped
BRPI0413032A (pt) diamidas de aminoacidos em uma posição não-(alfa), úteis como adjuvantes na administração de agentes biológicos ativos
CA2160689C (en) New method of treatment
葉周明 et al. Abdominal Apolexy: A Case Report
Hinshaw et al. Extracorporeal perfusion without exogenous anticoagulation: its protective role in endotoxin shock.
Varshney et al. Mesenchymal Stem Cell: Therapeutic Intervention in
Frey et al. Transfusion therapy

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII), 11, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.